Reslizumab: Intravenous Solution for Eosinophilic Asthma

Reslizumab, an intravenous drug, targets IL-5 to improve control of severe eosinophilic asthma.
Category
Drug
Where to get
Prescription only, administered intravenously in clinics
Prepared by Lee Cheng, reviewed by Dr. Helena Rodriguez

Reslizumab FAQ


Image credit: emedz.net

What is reslizumab used for?

Reslizumab is used together with other medicines to help control severe asthma in adults. Reslizumab affects your immune system, reducing levels of a certain type of white blood cell that may contribute to the symptoms of asthma. Reslizumab may also be used for purposes not listed in this medication guide.

What is reslizumab antibody?

Reslizumab is a humanized monoclonal antibody against human interleukin-5 (IL-5). Reslizumab binds specifically to IL-5, a key cytokine responsible for the differentiation, maturation, recruitment and activation of human eosinophils.

Is Reslizumab a cytokine?

Reslizumab is an interleukin-5 antagonist (IgG4 kappa). IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, and survival of eosinophils (a cell type associated with inflammation and an important component in the pathogenesis of asthma).

Is Reslizumab a biological medicine?

Reslizumab is a biological medicine. Biological medicines must be prescribed and dispensed by brand name, see Biological medicines and Biosimilar medicines, under Guidance on prescribing; record the brand name and batch number after each administration. For choice of therapy, see Asthma, acute and Asthma, chronic.

How much Reslizumab is in a ML?

The active substance is reslizumab. Each mL of concentrate contains 10 mg of reslizumab (10 mg/mL). Each vial of 2.5 mL contains 25 mg of reslizumab and each vial of 10 mL contains 100 mg of reslizumab. The other excipients are sodium acetate trihydrate, acetic acid glacial, sucrose and water for injections.

How much Reslizumab is in a vial?

Each vial of 2.5 mL contains 25 mg of reslizumab. Each vial of 10 mL contains 100 mg of reslizumab. Reslizumab is a humanised monoclonal antibody produced in mouse myeloma cells (NS0) by recombinant DNA technology. Each vial of 2.5 mL contains 0.05 mmol (1.15 mg) of sodium. Each vial of 10 mL contains 0.20 mmol (4.6 mg) of sodium.

Reslizumab References

If you want to know more about Reslizumab, consider exploring links below:

Explore Related Topics

Managing Side Effects: Tips for Those on Monoclonal Antibody Therapies

Side effects are a concern for many undergoing monoclonal antibody treatments. Share and discuss how to effectively manage these side effects.

Emerging Biologic Therapies: A New Horizon for Childhood Asthma Treatment?

Explore the potential of emerging biologic therapies for treating severe childhood asthma and discuss their accessibility and effectiveness.

What New Developments Are on the Horizon for Monoclonal Antibody Asthma Treatments?

Stay at the forefront of advancements in monoclonal antibody treatments for asthma. Discuss the latest research and what the future may hold.

Success Stories: How Monoclonal Antibodies Transformed My Asthma Management

If monoclonal antibodies have significantly impacted your asthma management, share your journey here. Let's inspire each other with success stories.

How Long Does It Take for Immunotherapy to Work on Asthma?

Share experiences or knowledge about the time frame for seeing improvements in asthma symptoms with immunotherapy. Help set realistic expectations for others considering this treatment.

The Cost of Immunotherapy for Asthma: Is It Worth It?

Discuss the financial aspects of undergoing immunotherapy for asthma, including insurance coverage and out-of-pocket expenses. Share tips on managing these costs.

Biologics Eligibility: Who Can Benefit?

Discuss the eligibility criteria for biologic therapies in asthma care and who stands to benefit the most.

Understanding the Side Effects of Biologic Treatments for Asthma

Delve into the potential side effects associated with biologic treatments for asthma and how to manage them.

Immunotherapy for Asthma: Miracle or Hype?

Share your experiences or opinions on whether immunotherapy is as effective as claimed or if it's just surrounded by hype.

Can Immunotherapy Reduce Asthma Attacks?

Discuss whether immunotherapy can significantly reduce the frequency and severity of asthma attacks. Share studies, personal stories, or expert opinions on its effectiveness.

How Does Immunotherapy Work Against Asthma?

Delve into the science behind immunotherapy and its mechanism of action in treating allergic asthma. Share knowledge or ask questions about how it targets the root causes of asthma.

The Cost vs. Benefit of Biologic Therapies for Asthma

Discuss the financial implications of biologic therapies for asthma and whether the benefits justify the cost.

Are Monoclonal Antibodies the Game-Changer for Severe Asthma?

Dive into the transformative potential of monoclonal antibodies for patients battling severe asthma. Let's discuss the real-world outcomes and share personal experiences.

Are Biologics Revolutionizing Asthma Treatment?

Explore how biologics are changing the landscape of asthma care and if they truly represent the future of treatment strategies.

Are Biologics the Future of Asthma Management?

Exploring the role of biologic therapies in treating severe asthma and whether they outperform traditional treatments.